Dasatinib

Common brands: Sprycel, Phyrago, Tasigna, Imatinib Mesylate, Imatinib

Top reporter: E.R. Squibb & Sons, L.L.C.

Corticosteroid [EPC]Kinase Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Nucleoside Metabolic Inhibitor [EPC]Loop Diuretic [EPC]
36,591
Total Reports
13,929
Serious Reports
3,681
Death Reports
30
Reported Reactions
Death Report Ratio: High (10.06%)

Patient Demographics

Male
16,492
Female
17,003

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Dasatinib.

# Reaction Reports % of Total
1 PLEURAL EFFUSION 3,217
9.1%
2 FATIGUE 2,529
7.2%
3 DIARRHOEA 2,160
6.1%
4 NAUSEA 2,131
6.0%
5 DEATH 2,087
5.9%
6 HEADACHE 1,995
5.6%
7 RASH 1,591
4.5%
8 DRUG INEFFECTIVE 1,509
4.3%
9 DYSPNOEA 1,493
4.2%
10 ADVERSE EVENT 1,469
4.2%
11 OFF LABEL USE 1,238
3.5%
12 HOSPITALISATION 1,204
3.4%
13 PULMONARY OEDEMA 1,005
2.8%
14 VOMITING 949
2.7%
15 PYREXIA 883
2.5%
16 MALIGNANT NEOPLASM PROGRESSION 843
2.4%
17 PNEUMONIA 787
2.2%
18 DRUG INTOLERANCE 777
2.2%
19 PAIN 771
2.2%
20 ANAEMIA 745
2.1%
21 ARTHRALGIA 682
1.9%
22 FLUID RETENTION 653
1.8%
23 THROMBOCYTOPENIA 642
1.8%
24 DRUG RESISTANCE 598
1.7%
25 MYALGIA 585
1.7%
26 MALAISE 571
1.6%
27 DECREASED APPETITE 570
1.6%
28 PLATELET COUNT DECREASED 569
1.6%
29 ASTHENIA 530
1.5%
30 CONSTIPATION 528
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.